Likes Subject
Good ol’ FredKerx and his “give us our $20!!!” Radtech 04/08/21 5:03 PM
Pushed out by Dem Deutschen Volk, but they PennyStock Alert 09/17/19 9:50 AM
After all these years, the cretin of all FredKerx 01/22/19 12:13 PM
RX price of < $5 pps AKBA post KarlDieGlatze 12/12/18 10:51 AM
Gestern ist der Untergang für KERX und AKBA. KarlDieGlatze 11/08/18 11:37 AM
On Friday, the day after this uninformative earnings KarlDieGlatze 11/07/18 3:46 PM
Liebe Fred, my retail friends who are rubes KarlDieGlatze 09/14/18 10:47 AM
Come on TWO PPS! We want these shares KarlDieGlatze 09/14/18 10:01 AM
Won’t see what coming??? These guys are untouchable... Radtech 09/13/18 11:33 PM
This board doesn't even have a moderator... Cuppy 09/13/18 9:52 PM
Just posted, “They want you to sell, they FredKerx 09/13/18 12:51 PM
Dave 1 hour ago FredKerx 09/12/18 8:33 AM
Why is kerx so low right now? kingofsting 09/06/18 11:40 AM
Liebe Fred, it's time to buy Overstock.com(OSTK)again......Byrne is KarlDieGlatze 08/16/18 8:31 PM
Schmeckles or Criminals, It's the Latter for Sure! KarlDieGlatze 07/26/18 5:19 PM
I am hearing that the official lawsuit is KarlDieGlatze 07/25/18 9:54 AM
Michele, the following post was blocked. They block FredKerx 07/21/18 5:12 PM
The following, in my opinion, as always.. FredKerx 07/21/18 1:05 PM
@Michele Your post reads.. FredKerx 07/18/18 9:10 AM
One has to envision our legal teams going KarlDieGlatze 07/15/18 3:36 PM
UNABLE TO POST THE FOLLOWING ON YHOO BOARD, FredKerx 07/15/18 10:11 AM
From the Akebia website.. FredKerx 07/13/18 10:17 PM
THIS POST WAS BLOCKED ON THE YHOO BOARD. FredKerx 07/13/18 10:03 PM
Folks, the following my take, based on my FredKerx 07/13/18 9:59 AM
(The following post seemingly blocked on Yhoo board).. FredKerx 07/12/18 10:18 AM
psea 9 hours ago FredKerx 07/08/18 10:38 AM
KERX Board has absolutely neglected its fiduciary responsibilities Radtech 07/08/18 10:09 AM
Attempted to post this on Yahoo, but their PSea 07/07/18 5:26 PM
Folks, my posts on KERX Yhoo board are FredKerx 07/07/18 9:45 AM
Last night posted a series of posts related FredKerx 07/07/18 7:45 AM
It appears they took down the class action FredKerx 07/06/18 2:52 PM
In an important meeting. FredKerx 07/06/18 1:44 PM
For whatever reasons, Sanofi's stock(SNY) has been reacting KarlDieGlatze 07/06/18 11:46 AM
@Anfuhrermitwut Guidance withdrawal since Nov. 7, 2017 — FredKerx 07/06/18 10:37 AM
Lieber Fred, will you be our LEAD PLAINTIFF KarlDieGlatze 07/06/18 9:28 AM
(Could not post the following on Yhoo board, FredKerx 07/06/18 7:59 AM
Lieber Frederick, Please articulate the correct strategy excluding KarlDieGlatze 07/05/18 10:54 AM
(This post also seemingly blocked on Yhoo board) FredKerx 07/04/18 6:39 PM
(Note: This post was blocked from publishing on FredKerx 07/04/18 4:17 PM
If SNY was being pushed out by Dem KarlDieGlatze 07/03/18 11:45 PM
Lieber Frederick, Make note of the ATM "Cantor KarlDieGlatze 07/03/18 4:25 PM
10Q expanded data surrounding License Agreement with Vifor: KarlDieGlatze 07/03/18 4:22 PM
Lieber Frederick, the termination terms you require as KarlDieGlatze 07/03/18 4:11 PM
Liebe Frederick, they are deleting so many of KarlDieGlatze 07/03/18 11:36 AM
If I were a lawyer while excluding the KarlDieGlatze 07/03/18 11:32 AM
Liebe Frederick, in case they DELETE my Yahoo KarlDieGlatze 07/03/18 10:43 AM
Liebe Frederick, what did you think about the KarlDieGlatze 07/03/18 9:42 AM
MY POSTS ARE BEING BLOCKED AGAIN! FredKerx 07/02/18 10:16 AM
And, those 4 million stolen shares on the KarlDieGlatze 07/01/18 3:03 PM
Liebe Fred, Is "that klarman guy" hitting the KarlDieGlatze 07/01/18 2:48 PM
Likes Subject

PennyStock Alert
09/17/19 9:50 AM
FredKerx
01/22/19 12:13 PM
KarlDieGlatze
12/12/18 10:51 AM
KarlDieGlatze
11/08/18 11:37 AM
KarlDieGlatze
09/14/18 10:47 AM
KarlDieGlatze
09/14/18 10:01 AM
FredKerx
09/13/18 12:51 PM
FredKerx
09/12/18 8:33 AM
kingofsting
09/06/18 11:40 AM
KarlDieGlatze
07/25/18 9:54 AM
FredKerx
07/21/18 1:05 PM
FredKerx
07/18/18 9:10 AM
KarlDieGlatze
07/15/18 3:36 PM
FredKerx
07/15/18 10:11 AM
FredKerx
07/13/18 10:17 PM
FredKerx
07/13/18 10:03 PM
FredKerx
07/13/18 9:59 AM
FredKerx
07/08/18 10:38 AM
FredKerx
07/07/18 9:45 AM
FredKerx
07/06/18 2:52 PM
FredKerx
07/06/18 1:44 PM
KarlDieGlatze
07/06/18 9:28 AM
KarlDieGlatze
07/03/18 11:45 PM
KarlDieGlatze
07/03/18 4:25 PM
KarlDieGlatze
07/03/18 11:36 AM
KarlDieGlatze
07/03/18 11:32 AM
KarlDieGlatze
07/03/18 10:43 AM
KarlDieGlatze
07/03/18 9:42 AM
FredKerx
07/02/18 10:16 AM
KarlDieGlatze
07/01/18 3:03 PM
KarlDieGlatze
07/01/18 2:48 PM

Keryx Biopharmaceuticals, Inc (KERX)

Followers
122
Posters
402
Posts (Today)
0
Posts (Total)
3329
Created
07/07/05
Type
Free
Moderators

 

 

 

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, and also affects a number of other key signal transduction pathways, including the JNK pathway, all of which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 has demonstrated both safety and clinical efficacy in several tumor types, both as a single agent and in combination with novel therapies. KRX-0401 is currently in Phase 3 clinical development for both multiple myeloma and refractory advanced colorectal cancer, and in Phase 2 clinical development for several other tumor types. Each of the KRX-0401 Phase 3 programs are being conducted under Special Protocol Assessment (SPA) agreements with the FDA. Keryx is also developing ZerenexTM (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. The Phase 3 clinical program of ZerenexTM in the treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is pending commencement under an SPA agreement with the FDA. Keryx also actively engages in business development activities that include seeking strategic relationships for its product candidates, as well as evaluating compounds and companies for in-licensing or acquisition.

Keryx is headquartered in New York City.

Keryx Biopharmaceuticals is traded on the Nasdaq Stock Market under the symbol "KERX."





Corporate Headquarters

 

Keryx Biopharmaceuticals, Inc.
750 Lexington Ave. - 20th Floor
New York, NY 10022
Phone: 1-212-531-5965
Fax: 1-212-531-5961
Contact Email
Investor Relations IR@keryx.com
Business Development BusDev@keryx.com
Clinical Trials ClinicalTrials@keryx.com
Employment Opportunities

Company Website
jobs@keryx.com

http://www.keryx.com/



 

Product candidate Target indication Development status
     
ZerenexTM (ferric citrate) Hyperphosphatemia in patients with end-stage renal disease U.S. Phase 3 program ongoing under SPA; 
Japan Phase 3 program ongoing by sublicensee (JT and Torii)

 

Recent News:

http://ih.advfn.com/p.php?pid=news&symbol=N%5EKERX

http://www.otcmarkets.com/stock/KERX/news  

http://investors.keryx.com/phoenix.zhtml?c=122201&p=irol-news&nyo=0

Charts:

Gallery views:

http://stockcharts.com/freecharts/gallery.html?kerx


 

                KERX - Daily Candlesticks  


Analyst's estimates and ratings: 
http://investing.money.msn.com/investments/analyst-ratings/?symbol=kerx

http://www.marketwatch.com/investing/stock/KERX/analystestimates?subview=snapshot&pg=analyst

 

The most recent Quarterly (10-Q)
 
 
  
Most Liked Posts
(Last 30 Days)
KERX Latest News
  • No Recent News Available for this company!
Most Liked Posts
(Last 30 Days)
New Post